Regional Sales Director, Structural Heart – TAVI (Southwest)
AbbottFull Time
Expert & Leadership (9+ years)
Candidates should possess deep domain knowledge of the Diagnostic Services industry and molecular diagnostic experience is strongly preferred, along with experience selling oncology-based tests and services into the Pathology and/or Oncology clinical communities. Demonstrated success in recruiting, hiring, developing, and retaining talent is required, as well as the ability to prioritize and align organizational goals and objectives, enable innovation, and develop and utilize cross-functional relationships.
The Regional Sales Manager will be responsible for leading a Regional Sales Team and exceeding sales goals across Tempus’s product portfolio, encompassing the creation and implementation of regional and territory business plans, the selection, hiring, training, development, and management of Clinical Account Executives within a defined geographic region, and managing business results, sales activities, and cross-functional initiatives. They will also be responsible for securing and analyzing relevant information, knowledge of the region, market intelligence, and political landscape to identify key issues and commit to action, as well as developing and conducting regional sales meetings, evaluating performance of Clinical Account Executives, identifying contracting opportunities, and management oversight of Tempus’s CRM solution for the defined geographic region, all while collaborating with cross-functional partners to access resources and maximize outcomes.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.